drugset / Trial / NCT01055691

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

NCT01055691

Phase 1 Completed 120 enrolled AstraZeneca Bristol-Myers Squibb · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of the study is to establish if the same amount of drug is absorbed into the blood after ingesting a combination dapagliflozin/metformin tablet vs. the individual dapagliflozin tablet and individual metformin tablet.

Timeline

Start
2010-01
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 2.5 mg Oral
Subject Dapagliflozin Small molecule 5 mg Oral
Subject Metformin Small molecule 850 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.